Resource Logo
NLM AIDSLINE

Analysis of multiple failure time data from an AIDS clinical trial.




 

Stat Med. 1997 Apr 30;16(8):951-61. Unique Identifier : AIDSLINE

The primary endpoint of AIDS prophylaxis trials is the occurrence of opportunistic infections. While the treatments are not expected to have an effect on the underlying HIV disease, an effect of treatments on mortality cannot be ruled out. Therefore, the primary analysis of these trials must be based on a combined endpoint of infection and survival times. There are several methods available for analysis of multiple failure time data. However, there is no standard method for combining mortality and other failures in these analyses. This paper explores the analysis of multiple infections in the context of a study in which treatments may have an effect on mortality. The methods are applied to an AIDS clinical trial of prophylaxis for fungal infections.

*AIDS-Related Opportunistic Infections/MORTALITY *Candidiasis/MORTALITY *Clinical Trials, Phase III/METHODS *Proportional Hazards Models *Randomized Controlled Trials/METHODS



 




Information in this article was accurate in September 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.